# CervoMed (CRVO) — Earnings

CRVO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crvo/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.84 |
| EPS estimate | −$0.66 |
| EPS surprise | −27.83% |
| Revenue surprise | −73.44% |
| Revenue | $322,569.00 |
| Revenue estimate | $1.2M |
| Reported | Nov 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1053691/000143774925033879/crvo20250930_10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 7, 2025 | −$0.66 | −$0.84 | -27.83% | $1.2M | $322,569.00 |
| Q2 2025 | Aug 8, 2025 | −$0.61 | −$0.70 | -13.88% | $1.4M | $1.8M |
| Q1 2025 | May 12, 2025 | −$0.63 | −$0.56 | 10.87% | $1.7M | $1.9M |
| Q4 2024 | Mar 17, 2025 | −$0.63 | −$0.77 | -21.39% | $1.5M | $2.2M |
| Q3 2024 | Nov 12, 2024 | −$0.41 | −$0.55 | -33.50% | $2.3M | $1.9M |
| Q2 2024 | Aug 9, 2024 | −$0.31 | −$0.27 | 11.76% | $1.6M | $3.3M |
| Q1 2024 | May 14, 2024 | −$0.39 | −$0.41 | -5.13% | $2.4M | $2.3M |
| Q4 2023 | Mar 29, 2024 | −$0.62 | −$0.12 | 81.45% | $1.0M | $2.5M |
| Q3 2023 | Nov 13, 2023 | −$0.95 | −$0.70 | 26.32% | — | $1.5M |
| Q2 2023 | Aug 8, 2023 | −$2.90 | −$3.04 | -5.01% | — | — |
| Q3 2022 | Nov 14, 2022 | −$3.09 | −$2.06 | 33.50% | — | — |
| Q2 2022 | Aug 12, 2022 | −$3.06 | −$3.09 | -0.98% | — | — |
| Q1 2022 | May 12, 2022 | −$2.63 | −$3.33 | -26.86% | — | — |
| Q3 2021 | Nov 10, 2021 | −$3.00 | −$9.00 | -200.00% | — | — |
| Q2 2021 | Aug 11, 2021 | −$3.38 | −$3.00 | 11.11% | — | — |
| Q4 2020 | Mar 17, 2021 | −$4.13 | −$4.50 | -9.09% | — | — |
| Q3 2020 | Nov 12, 2020 | −$4.13 | −$5.25 | -27.27% | — | — |
| Q1 2020 | May 11, 2020 | −$6.38 | −$5.25 | 17.65% | — | — |

## Frequently Asked Questions

### When did CervoMed (CRVO) last report earnings?

CervoMed last reported on Nov 7, 2025, covering fiscal Q3 2025.

### Did CRVO beat earnings estimates?

No. CervoMed reported EPS of −$0.84 for Q3 2025 against a −$0.66 estimate — a 27.83% miss.

### How much revenue did CRVO report last quarter?

CervoMed reported $322,569.00 in revenue for Q3 2025, against a consensus estimate of $1.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).